References

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 180 CE courses, most popular		$109Add to cart
Pick Your Courses
Up to 8 CE hours		$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Antiplatelet Medication Response Testing: Aspirin and Clopidogrel. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Antiplatelet Medication Response Testing: Aspirin and Clopidogrel (online CE course)
References

Agarwal S, Coakley M, Reddy K, Riddell A, Mallett S. Quantifying the effect of antiplatelet therapy: A comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry. Anesthesiology. 2006;105:676–83.
Bhatt DL. Aspirin Resistance: More than just a curiosity. J Am Coll Cardiol. 2004;43(6):1127-1129.
Bhatt DL, Grosser T. Enteric Coating and Aspirin. J Am Coll Cardiol. 2017;69(6): 603-612.
Clinical and Laboratory Standards Institute (CLSI). Platelet Function Testing by Aggregometry; Approved Guideline. CLSI document H58-A. Wayne, PA: CLSI; 2008.
Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol. 2001;88:230-235.
Gurbel PA, Tantry US. Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents. Circulation 2012;125:1276.
Homoncik M, Jilma B, Hergovich N, et al. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost. 2000;83(2):316-321.
Karon BS, Jaben E. Platelet function. Clin Lab News.2011;37(4):8-10.
Khan, H.; Kanny, O.; Syed, M.H.; Qadura, M. Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy.Int. J. Mol. Sci.2022,23, 11317. https://doi.org/10.3390/ijms231911317
Kickler ES. Aspirin resistance. Clin Lab News. 2007;33(6):10-12.
Kubica A, Kozinski M, Grezsk G, et al. Genetic determinants of platelet response to clopidogrel. J Thromb Thrombolysis. 2011November;32(4):459-466.
Malinin AL, Atar D, Callahan KP, et al. Effect of a single dose of aspirin on platelets in humans with multiple risk factors for coronary artery disease. Eur J Pharmacol. 2003;462:139-143.
Martin CP, Talbert RL. Aspirin resistance: An evaluation of current evidence and measurement methods. Pharmacotherapy. 2005;25(7):942-953.
Mason PJ, Jacobs AK, Freedman JE. Aspirin resistance and atherothrombotic disease. J Am Coll Cardiol. 2005;46:986-993.
McKenzie S, Williams JL. Clinical Laboratory Hematology. 3rd ed. Upper Saddle River, NJ: Pearson; 2015.
Michelson AD. Platelet function testing in cardiovascular diseases. Circulation. 2004;110:489-493.
Nguyen T, Diodati JG, Pharand C. Resistance to clopidogrel: A review of the evidence. J Am Coll Cardiol. 2005;45(8):1157-1164.
Serebruany VL, Steinhubl SR, Berger PB, et al. Variability in patient responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol. 2005;45(2):246-251.
US Preventive Services Taskforce. (2022, April 26). Aspirin use to prevent cardiovascular disease: Preventive medication. Recommendation: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication
Wiviott SD, Antman EM. Clopidogrel resistance: A new chapter in a fast-moving story. Circulation. 2004;109(25):3064-3067.